The Bottom Line: Tragedy in Oxford should be a learning moment for individuals who use over-the-counter stimulants

Two University of Mississippi students were found dead this week. Aidan Hamilton, an 18-year-old freshman from Englewood, Colorado, and Robert Strang, a 20-year-old junior from Atlanta, died in separate places -- one in a campus dorm, one in an off-campus home--after a loud football weekend in Oxford.

Packaged kratom sold from a retail store was recovered at both scenes. Authorities have not confirmed that kratom, or any other substance, caused either death. Autopsies and toxicology are still pending. That uncertainty is real, and it should be respected. So should the families. They asked for privacy. They should have it.

We pause here because two young men are gone, and no argument about policy or advertising is larger than that. Parents sent their sons to college. They did not send them to come home in caskets.

Kratom is not a mystery plant from a rumor mill. It comes from Mitragyna speciosa, a tree in the coffee family native to Southeast Asia. At low doses it acts like a stimulant. At higher doses it acts like an opioid. It is sold as powder, capsules, shots, and flavored extracts in gas stations, smoke shops, and online.

The Food and Drug Administration has not approved it as a drug, a dietary supplement, or a food additive. The agency has warned of liver toxicity, seizures, substance use disorder, and contamination. The Drug Enforcement Administration lists it as a drug of concern. Fatal cases linked to kratom alone appear rare; deaths more often involve other drugs, alcohol, or adulterated products.

That does not make an unregulated opioid-like product sitting next to chips and energy drinks a public-health triumph. It makes it a gray-market product with real risk and almost no federal quality control. Concentrated extracts, including 7-hydroxymitragynine products sometimes marketed as far more potent than morphine, have only sharpened the concern.

If kratom were harmless, states would not keep banning it.

They have. Lists shift as legislatures and health departments move, but a consistent group of states has prohibited sale and possession of kratom or its main alkaloids: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, North Dakota, Tennessee, Vermont, and Wisconsin. Massachusetts and California have imposed additional commercial or emergency restrictions.

There is a reason those states acted. Lawmakers do not usually schedule a gas-station herb as a controlled substance for sport. They do it after poison-center calls, addiction clinics, and death investigations pile up.

Oxford itself banned the product locally even while Mississippi left it legal statewide. That local judgment should tell you something.

Today in Fort Smith has been approached by businesses in Oklahoma that sell kratom products. It is not our practice to turn away honest advertisers. News outlets like ours run on advertising revenue. . We know that. There are still lines we will not cross.

That has been our policy for dangerous products and for dangerous politics. Kratom sits uncomfortably in both categories: a loosely regulated psychoactive sold as if it were a vitamin, and a political fight in which industry money and “personal freedom” slogans collide with coroners and college towns.

We believe in personal responsibility. Adults make choices. Overdoses do not happen in a vacuum. People who mix substances, chase a high, or treat a gas-station bottle like a prescription are not passive victims of a billboard.

Accountability starts with the person who swallows the product. It also starts with the seller who packages an opioid-acting extract in candy flavors and the platform that pretends “herbal” means “safe.”

Legal is not the same as wise. Available is not the same as harmless.

Our thoughts are with the Hamilton and Strang families, and with every family that has lost a child to illegal drugs or to the misuse of something that looked legal enough to buy without a prescription.

Grief does not require a completed toxicology report. Neither does caution.

We will not carry advertising that treats kratom like a lifestyle brand.

We will not pretend a product the FDA will not bless and a dozen states will not allow is just another line item. If that costs us a check from Oklahoma, so be it. Some revenue is not worth the company it keeps.

Two students are dead. The tests are not back. The warning from Oxford already is. That is enough.